Xencor, Inc. (XNCR): Price and Financial Metrics
XNCR Price/Volume Stats
| Current price | $9.65 | 52-week high | $27.24 |
| Prev. close | $9.12 | 52-week low | $7.16 |
| Day low | $9.23 | Volume | 523,516 |
| Day high | $9.89 | Avg. volume | 792,184 |
| 50-day MA | $9.17 | Dividend yield | N/A |
| 200-day MA | $17.19 | Market Cap | 686.80M |
XNCR Stock Price Chart Interactive Chart >
Xencor, Inc. (XNCR) Company Bio
Xencor Inc. is a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune diseases and cancer. The company was founded in 1997 and is based in Monrovia, California.
XNCR Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
XNCR Price Returns
| 1-mo | 20.85% |
| 3-mo | -30.43% |
| 6-mo | -61.92% |
| 1-year | -55.96% |
| 3-year | -55.79% |
| 5-year | -67.84% |
| YTD | -58.01% |
| 2024 | 8.24% |
| 2023 | -18.47% |
| 2022 | -35.09% |
| 2021 | -8.04% |
| 2020 | 26.87% |